You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 81 No. 4, April 1960 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antibacterial Activity of Weak Solutions of Aluminum Salts

IRVIN H. BLANK, Ph.D.; RUTH K. DAWES, B.S.

AMA Arch Derm. 1960;81(4):565-569.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It was as early as 1857 that Burow1 first recommended a weak solution of aluminum acetate as a wet dressing for the treatment of numerous cutaneous diseases. He had previously learned from a chemist that this aluminum salt preserved certain organic materials used in the manufacture of sugar. Since Pasteur's classical discoveries were made between 1860 and 1865, Burow could not have known that the pharmacological effectiveness of aluminum acetate depended even in part on antibacterial action. By the early part of the twentieth century, Burow's solution was frequently used in the treatment of diseases of bacterial origin, such as furunculosis.2 In more recent years, the antibacterial property of Burow's solution is seldom mentioned in the literature, and its pharmacological effect is attributed to astringent and buffer action.

Kionka3 reported that a 20% solution of a mixture of aluminum lactate and tartrate killed streptococci in 5 minutes. . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From The Dermatological Research Laboratories of the Department of Dermatology, Harvard Medical School, at the Massachusetts General Hospital, Boston.


Footnotes

Submitted for publication July 13, 1959.

This work was supported by a grant from Reheis Company, Inc., Berkeley Heights, N.J.

Read before the Section on Dermatology at the 108th Annual Meeting of the American Medical Association, Atlantic City, N.J., June 10, 1959.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.